This study aimed to investigate the effects of high-intensity intermittent exercise and moderate-intensity continuous exercise on serum irisin levels, disease activity, functional status, and quality of life in patients with axial spondyloarthritis.
Who can participate
Age range18 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients diagnosed with axillary spondyloarthropathy according to ASAS diagnostic criteria,
* Having a high disease severity (ASDAS-CRP above 2.1),
* Being sedentary (not engaging in physical activity at least 3 days a week in the last 3 months),
* Having no change in ankylosing spondylitis medical treatment in the last 3 months,
* Not having any orthopedic, neurological, cardiovascular, or mental disease that would affect exercise,
* Not using any assistive devices for ambulation,
* Having a BMI of 25 kg/m2 or less,
* Male and female patients aged 18-50 years.
Exclusion Criteria:
* Those with uncontrolled cardiopulmonary disease (such as hypertension, chronic obstructive pulmonary disease, heart failure),
* Having comorbidities that reduce exercise capacity,
* Pregnancy,
* Malignancy,
* Those with a recent history of surgery,
* Those who have engaged in regular exercise (aquatic exercise, land exercise, etc.) in the previous 3 months
What they're measuring
1
serum irisin level
Timeframe: Before treatment and after treatment (week 8)